Neuropeptide Y Y4 Receptor Homodimers Dissociate upon Agonist Stimulation
- 1 December 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 307 (3) , 1120-1126
- https://doi.org/10.1124/jpet.103.055673
Abstract
The pancreatic polypeptide-fold family of peptides consists of three 36-amino acid peptides, namely neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP). These peptides regulate important functions, including food intake, circadian rhythms, mood, blood pressure, intestinal secretion, and gut motility, through four receptors: Y1, Y2, Y4, and Y5. Additional receptor subtypes have been proposed based on pharmacology observed in native tissues. Recent studies with other G-protein-coupled receptors have shown that homo- and heterodimerization may be important in determining receptor function and pharmacology. In the present study, the recently cloned rhesus (rh) Y4 receptor was evaluated using radioligand binding, and the pharmacological profile was found to be very similar to the human Y4 receptor. To study homo- and heterodimerization involving the Y4 receptor using bioluminescence resonance energy transfer 2 (BRET2), the carboxy termini of the rhesus Y1, Y2, Y4, and Y5 receptors were fused to Renilla luciferase, and rhY4 was also fused to green fluorescent protein. Dimerization was also studied using Western blot analysis. Using both BRET2 and Western analysis, we found that the rhY4 receptor is present at the cell surface as a homodimer. Furthermore, agonist stimulation using the Y4-selective agonists PP and 1229U91 can dissociate these dimers in a concentration-dependent manner. In contrast, rhY4 did not heterodimerize with other members of the NPY receptor family or with human opioid δ and μ receptors. Therefore, homodimerization is an important component in the regulation of the Y4 receptor.This publication has 34 references indexed in Scilit:
- The Use of Bioluminescence Resonance Energy Transfer 2 to Study Neuropeptide Y Receptor Agonist-Induced β-Arrestin 2 InteractionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor SubtypesExperimental Biology and Medicine, 2003
- Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and FunctionAnnual Review of Pharmacology and Toxicology, 2002
- Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy TransferPublished by Elsevier ,2001
- AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestrationNature, 2000
- Detection of β 2 -adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)Proceedings of the National Academy of Sciences, 2000
- Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor DimerizationJournal of Biological Chemistry, 1999
- Dimerization of the δ Opioid Receptor:Journal of Biological Chemistry, 1997
- Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YYJournal of Biological Chemistry, 1995
- High-affinity neuropeptide Y receptor antagonists.Proceedings of the National Academy of Sciences, 1995